Remove www.gov.uk guidance access-consortium
article thumbnail

Enabling Global Pharma Innovation: Delivering for Patients

ISPE

Most important, the lack of global regulatory harmonization reduces incentives for industry to invest in these innovations, which, in many ways, limits access of safe, effective, and quality drug products to patients globally.

FDA 52